查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
COVID-19 影響分析的學名藥市場，按類型、按給藥途徑、按產品、按應用、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1339904

COVID-19 影響分析的學名藥市場，按類型、按給藥途徑、按產品、按應用、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Generic Pharmaceuticals Market with COVID-19 Impact Analysis, By Type, By Route of Administration, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 374 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年學名藥市場規模為 3617.010 億美元，2023 年至 2030 年年複合成長率為 8.31%。

學名藥市場-市場動態：

  • 慢性病發病率增加。
  • 慢性病發病率的上升是學名藥市場的主要驅動力之一。隨著越來越多的人被診斷為慢性病，他們會尋求其他藥物來治療。品牌藥物的成本較高，而學名藥的成本較低，並且與品牌藥物的化學成分相同。由於學名藥的成本較低、化學成分的一致性和效力較高，患者選擇學名藥而非品牌藥。由於慢性病治療時間的延長，學名藥的銷量也隨之增加。例如，世界衛生組織 (WHO) 預測未來 10 年慢性病相關死亡人數將增加 17%。

學名藥市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球學名藥市場在預測期內（2023-2030 年）每年將以 8.31% 左右的年複合成長率成長
  • 根據類型細分，預計簡單學名藥產品將在 2022 年佔據最大市場佔有率
  • 從應用來看，2022年心血管是主導類型
  • 從產品細分看，2022年小分子為主導類型
  • 按給藥途徑細分，2022年口服為主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

學名藥市場-細分分析：

  • 全球學名藥市場根據類型、給藥途徑、產品、應用和地區進行細分。
  • 市場根據類型分為幾類：簡單學名藥、特殊學名藥和生物學名藥。簡單學名藥領域主導著市場。簡單的學名藥需要進行生物等效性研究，並有明確的開發計劃和監管方法。這些產品的化學成分與參考產品相同，市場上已經充斥著簡單的學名藥產品。儘管如此，由於政府試圖削減藥品醫療保健支出並增加新的批准和上市，預計市場將擴大。
  • 市場根據給藥途徑分為幾類：口服、注射、吸入和其他。口腔細分市場佔據主導地位。口服劑量的許多好處，包括其簡單性和無需護理需求，提高了患者的接受度和依從性。為了治療 COVID-19 患者，Zenera Pharma 於 2022 年 9 月推出了 Paxlovid 的學名藥。每盒這些口服藥物包含 20 粒 Nirmatrelvir 藥丸，售價為 63.74 美元。

學名藥市場 - 地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。越來越多的政府優惠舉措，加上產品上市數量和學名藥需求的不斷增加，是北美地區的主要收入驅動力。

學名藥市場-競爭格局：

  • 由於未來幾年空調需求的持續發展，全球空氣對空氣熱泵市場由國際和本地生產商組成，使其成為世界上最具競爭力的行業之一。公司通過多種管道銷售產品，包括企業網站、電子商務網站、零售商、分銷商和最終消費者。產品製造商在多個方面進行競爭，包括產品成本、性能、產品製造、分銷、聲譽和可用性。
  • 企業用來擴大影響力和擴大市場佔有率的一些主要技術包括新產品發布、產品網路開發、研發支出以及併購。例如，2022 年 11 月，美國衛生當局允許 Glenmark Pharmaceuticals 在美國銷售苯丁酸鈉片劑，這是一種用於治療尿素循環障礙的藥物。

最近的發展：

2022 年 10 月，Glenmark 的美國分部將用於治療多發性硬化症的學名藥芬戈莫德膠囊引入美國市場。

該研究的主要特點：

  • 這項擬議的學名藥市場研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年
  • 該報告為客戶提供有關學名藥市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了學名藥市場有吸引力的投資主張矩陣
  • 總體報告確定了新的投資機會、老牌企業面臨的挑戰以及維持學名藥市場的成長因素
  • COVID-19 對學名藥市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將涵蓋對新冠疫情后學名藥市場的詳細見解。
  • 為了讓本報告的用戶全面了解學名藥市場，我們還包括學名藥市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這將幫助用戶了解在學名藥市場營運的參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球學名藥市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師

目錄

第一章：學名藥市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的學名藥市場片段
    • 按給藥途徑分類的學名藥市場片段
    • 按產品分類的學名藥市場片段
    • 按應用分類的學名藥市場片段
    • 按國家/地區分類的學名藥市場摘要
    • 按地區分類的學名藥市場片段
  • 競爭洞察

第 3 章：學名藥主要市場趨勢

  • 學名藥市場促進因素
    • 市場促進因素的影響分析
  • 學名藥市場限制
    • 市場限制影響分析
  • 學名藥市場機會
  • 學名藥市場未來趨勢

第 4 章：學名藥行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：學名藥市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：學名藥市場格局

  • 2022 年學名藥市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：學名藥市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 簡單泛型
    • 專業學名藥
    • 生物學名藥

第 8 章：學名藥市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 口服
    • 可注射
    • 吸入式
    • 其他

第 9 章：學名藥市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 小分子
    • 大分子

第 10 章：學名藥市場 -按應用

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 中樞神經系統疾病
    • 呼吸疾病
    • 激素及相關疾病
    • 胃腸道疾病
    • 心血管疾病
    • 傳染性疾病
    • 癌症
    • 糖尿病
    • 其他

第 11 章：學名藥市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 北美學名藥主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按管理途徑）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲學名藥主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按類型）
    • 歐洲市場規模和預測（按管理途徑）
    • 歐洲市場規模和預測（按產品）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區學名藥主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按類型）
    • 亞太地區市場規模和預測（按管理途徑）
    • 亞太地區市場規模和預測（按產品）
    • 亞太地區市場規模和預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲學名藥主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按類型）
    • 拉丁美洲市場規模和預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按產品）
    • 拉丁美洲市場規模和預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲非專利藥品主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 學名藥行業

  • 競爭儀表板
  • 公司簡介
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Teva Pharmaceutical Industries
    • Sun Pharmaceutical Industries
    • Sandoz (a subsidiary of Novartis)
    • Mylan (now part of Viatris)
    • Lupin Pharmaceuticals
    • Hikma Pharmaceuticals
    • Glenmark Pharmaceuticals
    • Fresenius Kabi
    • Endo International (through its subsidiary Par Pharmaceutical)
    • Dr. Reddy's Laboratories
    • Cipla
    • Aurobindo Pharma
    • Apotex

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1628

REPORT HIGHLIGHT

Generic Pharmaceuticals Market size was valued at USD 361,701.0 Million in 2022, expanding at a CAGR of 8.31% from 2023 to 2030.

Generic medicines are non-branded drugs with the same active components, dosage form, potency, and intended purpose as brand-name drugs. Following the termination of the patent protection for the original medicine, these products are created and marketed. To assure their safety, quality, and efficacy, generic medications must pass stringent regulatory clearance procedures. Generic medicines are often less expensive than name-brand medications since there are no expenditures associated with research and development. While preserving similar therapeutic efficacy to their branded versions, they help extend access to vital pharmaceuticals and are crucial in lowering healthcare costs.

Generic Pharmaceuticals Market- Market Dynamics:

  • Increasing incidence of chronic diseases.
  • The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more people are given a chronic disease diagnosis, they seek out additional medications to treat it. Branded medications cost more, whereas generic medications cost less and share the same chemical make-up as branded medications. Patients choose generic medications over branded medications due to the lower cost, consistency in chemical makeup, and potency of generic medications. As a result of the extended duration of therapy for chronic diseases, generic medicine sales also rise. For instance, the WHO (World Health Organization) predicts a 17% rise in the number of chronic disease-related fatalities during the next ten years.

Generic Pharmaceuticals Market- Key Insights:

  • As per the analysis shared by our research analyst, the global generic pharmaceutical market is estimated to grow annually at a CAGR of around 8.31% over the forecast period (2023-2030)
  • Based on type segmentation, simple generic products were predicted to show maximum market share in the year 2022
  • Based on application, cardiovascular was the leading type in 2022
  • Based on product segmentation, the small molecule was the leading type in 2022
  • Based on route of administration segmentation, oral was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Generic Pharmaceuticals Market- Segmentation Analysis:

  • The Global Generic Pharmaceuticals Market is segmented based on Type, Route of Administration, Product, Application, and Region.
  • The market is divided into categories based on Type: Simple Generics, Specialty Generics, and Biosimilars. The Simple Generics sector dominates the market. The simple generic products need to conduct bioequivalence studies and have a defined development plan and regulatory approach. These items are chemically identical to their reference counterparts, and the market is already overflowing with straightforward generic products. Nevertheless, the market is anticipated to expand as a result of government attempts to cut healthcare spending on medicines and increase new approvals and launches.
  • The market is divided into categories based on Route of Administration: Oral, Injectable, Inhalable, and Others. The oral segment dominates the market. The many benefits of oral dose, including its simplicity and lack of nursing needs, increase patient acceptance and compliance. For the treatment of COVID-19 patients, Zenera Pharma introduced a generic version of Paxlovid in September 2022. Each box of these oral medications, which contains 20 Nirmatrelvir pills, costs USD 63.74.

Generic Pharmaceuticals Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. An increasing number of favorable government initiatives coupled with the rising number of product launches and demand for generic drugs is a key revenue driver in North American region.

Generic Pharmaceuticals Market- Competitive Landscape:

  • Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution, reputation, and availability.
  • Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, Product network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The US health authority gave Glenmark Pharmaceuticals permission to sell sodium phenylbutyrate tablets, a medication used to treat urea cycle disorders, in the US.

Recent Developments:

In October 2022, Generic Fingolimod capsules, utilized for the treatment of multiple sclerosis, were introduced to the American market by Glenmark's American-based division.

Key features of the study:

  • This proposed research study on Generic Pharmaceuticals market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Generic Pharmaceuticals market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Generic Pharmaceuticals market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Generic Pharmaceuticals market
  • Impact of COVID-19 on Generic Pharmaceuticals market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Generic Pharmaceuticals market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Generic Pharmaceuticals market, we have also included competitive landscape and key innovator analysis for the Generic Pharmaceuticals market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Generic Pharmaceuticals market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Generic Pharmaceuticals market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC PHARMACEUTICALS MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz (a subsidiary of Novartis)
  • Mylan (now part of Viatris)
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Endo International (through its subsidiary Par Pharmaceutical)
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Apotex

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE

  • Simple Generics
  • Specialty Generics
  • Biosimilars

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectable
  • Inhalable
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cancer
  • Diabetes
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Pharmaceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Pharmaceuticals Market Snippet by Type
    • 2.1.2. Generic Pharmaceuticals Market Snippet by Route of Administration
    • 2.1.3. Generic Pharmaceuticals Market Snippet by Product
    • 2.1.4. Generic Pharmaceuticals Market Snippet by Application
    • 2.1.5. Generic Pharmaceuticals Market Snippet by Country
    • 2.1.6. Generic Pharmaceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Pharmaceuticals Key Market Trends

  • 3.1. Generic Pharmaceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Pharmaceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Pharmaceuticals Market Opportunities
  • 3.4. Generic Pharmaceuticals Market Future Trends

4. Generic Pharmaceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Pharmaceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Pharmaceuticals Market Landscape

  • 6.1. Generic Pharmaceuticals Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Pharmaceuticals Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Simple Generics
    • 7.1.3. Specialty Generics
    • 7.1.4. Biosimilars

8. Generic Pharmaceuticals Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable
    • 8.1.4. Inhalable
    • 8.1.5. Others

9. Generic Pharmaceuticals Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 9.1.2. Small Molecule
    • 9.1.3. Large Molecule

10. Generic Pharmaceuticals Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 10.1.2. Central Nervous System Disorders
    • 10.1.3. Respiratory Diseases
    • 10.1.4. Hormones & Related Diseases
    • 10.1.5. Gastrointestinal Diseases
    • 10.1.6. Cardiovascular Diseases
    • 10.1.7. Infectious Diseases
    • 10.1.8. Cancer
    • 10.1.9. Diabetes
    • 10.1.10. Others

11. Generic Pharmaceuticals Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Generic Pharmaceuticals Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Generic Pharmaceuticals Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Generic Pharmaceuticals Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Generic Pharmaceuticals Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Generic Pharmaceuticals Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Generic Pharmaceuticals Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Zydus Cadila
    • 12.2.2. Torrent Pharmaceuticals
    • 12.2.3. Teva Pharmaceutical Industries
    • 12.2.4. Sun Pharmaceutical Industries
    • 12.2.5. Sandoz (a subsidiary of Novartis)
    • 12.2.6. Mylan (now part of Viatris)
    • 12.2.7. Lupin Pharmaceuticals
    • 12.2.8. Hikma Pharmaceuticals
    • 12.2.9. Glenmark Pharmaceuticals
    • 12.2.10. Fresenius Kabi
    • 12.2.11. Endo International (through its subsidiary Par Pharmaceutical)
    • 12.2.12. Dr. Reddy's Laboratories
    • 12.2.13. Cipla
    • 12.2.14. Aurobindo Pharma
    • 12.2.15. Apotex

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Pharmaceuticals Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Generic Pharmaceuticals Market, by Type 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Generic Pharmaceuticals Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Generic Pharmaceuticals Market, by Product 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Pharmaceuticals Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Pharmaceuticals Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Generic Pharmaceuticals Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Europe Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Latin America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Germany Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE India Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Brazil Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Saudi Arabia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)